Intraspinal Abscess Treatment Segmentation
Type (Epidural Abscess, Subdural Abscess, Intramedullary Abscess)
Based on type, the epidural abscess segment is predicted to capture the largest share of 42.5% in the intraspinal abscess treatment market over the assessed timeline. This kind of spinal infection is more prevalent than the other type, making it a priority for both consumers and healthcare service providers. The close association of its occurrence with diabetes and post-surgical complications also propels the patient pool of this segment. According to the CDC report, the incidences of infections after surgeries increased by 15.3% by 2024 from 2020. Additionally, NIH revealed that the rate of enrollment for diagnosis in this discipline rose by 25.4% in the U.S. and Europe due to the increased popularity and adoption of MRI.
End user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)
In terms of end users, the hospitals segment is anticipated to show dominance over the intraspinal abscess treatment market with a share of 55.4% by the end of 2037. The essentiality of hospitalization to treat afflicted patients is the primary driver behind this segment’s augmentation. As per WHO, over 65.3% of spinal abscess candidates need to be admitted to hospitals for complete treatment. Moreover, the cost of surgical interventions performed in these organizations is remarkably high, averaging up to USD 18,000.5 per case, resulting in higher revenue generation than in other clinical settings. Further, the proven efficacy of MRI-guided drainage and targeted antibiotic therapy, improving recovery times by 30.5% in leading U.S. hospitals, are also contributing to this segment’s growth.
Our in-depth analysis of the global intraspinal abscess treatment market includes the following segments:
|
Type |
|
|
Treatment |
|
|
End user |
|
